Prognostic significance of MRI-detected extramural venous invasion according to grade and response to neo-adjuvant treatment in locally advanced rectal cancer A national cohort study after radiologic training and reassessment

被引:2
作者
Geffen, Eline G. M. van [1 ,2 ]
Nederend, Joost [3 ]
Sluckin, Tania C. [1 ,2 ]
Hazen, Sanne-Marije J. A. [1 ,2 ]
Horsthuis, Karin [2 ,4 ]
Beets-Tan, Regina G. H. [5 ,6 ,7 ]
Marijnen, Corrie A. M. [8 ,9 ]
Tanis, Pieter J. [2 ,10 ,11 ]
Kusters, Miranda [1 ,2 ,12 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam UMC Locat, Dept Surg, NL-1117 Amsterdam, Netherlands
[2] Canc Ctr Amsterdam, Treatment & Qual Life & Imaging & Biomarkers, Amsterdam, Netherlands
[3] Catharina Hosp, Dept Radiol, Michelangelolaan 2, Eindhoven, Netherlands
[4] Vrije Univ Amsterdam, Amsterdam UMC Locat, Dept Radiol & Nucl Med, NL-1117 Amsterdam, Netherlands
[5] Netherlands Canc Inst, Dept Radiol, Plesmanlaan 121, Amsterdam, Netherlands
[6] Univ Maastricht, GROW Sch Oncol & Dev Biol, Dept Pathol, Univ singel 40, Maastricht, Netherlands
[7] Univ Southern Denmark, Odense Univ Hosp, Dept Radiol, Dept Clin Res, Campusvej 55, DK-5230 Odense, Denmark
[8] LUMC, Dept Radiat Oncol, Albinusdreef 2, Leiden, Netherlands
[9] Netherlands Canc Inst, Dept Radiat Oncol, Plesmanlaan 121, Amsterdam, Netherlands
[10] Univ Amsterdam, Amsterdam UMC Locat, Dept Surg, Meibergdreef 9, Amsterdam, Netherlands
[11] Erasmus MC, Dept Surg Oncol & Gastrointestinal Surg, Rotterdam, Netherlands
[12] Univ Amsterdam, Canc Ctr Amsterdam, Amsterdam UMC, Dept Surg, POB 7057, NL-1007 MB Amsterdam, Netherlands
来源
EJSO | 2024年 / 50卷 / 06期
关键词
LATERAL LYMPH-NODES; ADJUVANT CHEMOTHERAPY; VASCULAR INVASION; TUMOR DEPOSITS; THERAPY; CHEMORADIOTHERAPY; RADIOTHERAPY; SURVIVAL; SOCIETY;
D O I
10.1016/j.ejso.2024.108307
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Detection of grade 3 -4 extra mural venous invasion (mrEMVI) on magnetic resonance imaging (MRI) is associated with an increased distant metastases (DM) -rate. This study aimed to determine the impact of different grades of mrEMVI and their disappearance after neoadjuvant therapy. Methods: A Dutch national retrospective cross-sectional study was conducted, including patients who underwent resection for rectal cancer in 2016 from 60/69 hospitals performing rectal surgery. Patients with a cT3-4 tumour <= 8 cm from the anorectal junction were selected and their MRI-scans were reassessed by trained abdominal radiologists. Positive mrEMVI grades (3 and 4) were analyzed in regard to 4-year local recurrence (LR), DM, disease-free survival (DFS) and overall survival (OS). Results: The 1213 included patients had a median follow-up of 48 months (IQR 30 -54). Positive mrEMVI was present in 324 patients (27%); 161 had grade 3 and 163 had grade 4. A higher mrEMVI stage (grade 4 vs grade 3 vs no mrEMVI) increased LR-risk (21% vs 18% vs 7%, <0.001) and DM-risk (49% vs 30% vs 21%, p < 0.001) and decreased DFS (42% vs 55% vs 69%, p < 0.001) and OS (62% vs 76% vs 81%, p < 0.001), which remained independently associated in multivariable analysis. When mrEMVI had disappeared on restaging MRI, DM -rate was comparable to initial absence of mrEMVI (both 26%), whereas LR -rate remained high (22% vs 9%, p = 0.006). Conclusion: The negative oncological impact of mrEMVI on recurrence and survival rates was dependent on grading. Disappearance of mrEMVI on restaging MRI decreased the risk of DM, but not of LR.
引用
收藏
页数:8
相关论文
共 30 条
[1]   Prognostic value of MRI in assessing extramural venous invasion in rectal cancer: multi-readers' diagnostic performance [J].
Bae, Jae Seok ;
Kim, Se Hyung ;
Hur, Bo Yun ;
Chang, Won ;
Park, Juil ;
Park, Hye Eun ;
Kim, Jung Ho ;
Kang, Hyo-Jin ;
Yu, Mi Hye ;
Han, Joon Koo .
EUROPEAN RADIOLOGY, 2019, 29 (08) :4379-4388
[2]   Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting [J].
Beets-Tan, Regina G. H. ;
Lambregts, Doenja M. J. ;
Maas, Monique ;
Bipat, Shandra ;
Barbaro, Brunella ;
Curvo-Semedo, Luis ;
Fenlon, Helen M. ;
Gollub, Marc J. ;
Gourtsoyianni, Sofia ;
Halligan, Steve ;
Hoeffel, Christine ;
Kim, Seung Ho ;
Laghi, Andrea ;
Maier, Andrea ;
Rafaelsen, Soren R. ;
Stoker, Jaap ;
Taylor, Stuart A. ;
Torkzad, Michael R. ;
Blomqvist, Lennart .
EUROPEAN RADIOLOGY, 2018, 28 (04) :1465-1475
[3]   Benchmarking recent national practice in rectal cancer treatment with landmark randomized controlled trials [J].
Borstlap, W. A. A. ;
Deijen, C. L. ;
den Dulk, M. ;
Bonjer, H. J. ;
van de Velde, C. J. ;
Bemelman, W. A. ;
Tanis, P. J. ;
Aalbers, A. ;
Acherman, Y. ;
Algie, G. D. ;
von Geu-sau, B. Alting ;
Amelung, F. ;
Aukema, T. S. ;
Bakker, I. S. ;
Bartels, S. A. ;
Basha, S. ;
Bastiaansen, A. J. N. M. ;
Belgers, E. ;
Bleeker, W. ;
Blok, J. ;
Bosker, R. J. I. ;
Bosmans, J. W. ;
Boute, M. C. ;
Bouvy, N. D. ;
Bouwman, H. ;
Brandt-Kerkhof, A. ;
Brinkman, D. J. ;
Bruin, S. ;
Bruns, E. R. J. ;
Burbach, J. P. M. ;
Burger, J. W. A. ;
Buskens, C. J. ;
Clermonts, S. ;
Coene, P. P. L. O. ;
Compaan, C. ;
Consten, E. C. J. ;
Darbyshire, T. ;
de Mik, S. M. L. ;
de Graaf, E. J. R. ;
de Groot, I. ;
Cappel, R. J. L. de Vos Tot Nederveen ;
de Wilt, J. H. W. ;
van der Wolde, J. ;
den Boer, F. C. ;
Dekker, J. W. T. ;
Demirkiran, A. ;
Derkx-Hendriksen, M. ;
Dijkstra, F. R. ;
van Duijvendijk, P. ;
Dunker, M. S. .
COLORECTAL DISEASE, 2017, 19 (06) :O219-O231
[4]   Adjuvant chemotherapy after preoperative (chemo) radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data [J].
Breugom, Anne J. ;
Swets, Marloes ;
Bosset, Jean-Francois ;
Collette, Laurence ;
Sainato, Aldo ;
Cionini, Luca ;
Glynne-Jones, Rob ;
Counsell, Nicholas ;
Bastiaannet, Esther ;
van den Broek, Colette B. M. ;
Liefers, Gerrit-Jan ;
Putter, Hein ;
van de Velde, Cornelis J. H. .
LANCET ONCOLOGY, 2015, 16 (02) :200-207
[5]  
Cancer Council Australia Melanoma Guidelines, ogy Clinical Practice Guidelines for the Diagnosis and Treat
[6]   Adjuvant chemotherapy may improve disease-free survival in patients with rectal cancer positive for MRI-detected extramural venous invasion following chemoradiation [J].
Chand, M. ;
Rasheed, S. ;
Heald, R. ;
Swift, I. ;
West, N. ;
Rao, S. ;
Tekkis, P. ;
Brown, G. .
COLORECTAL DISEASE, 2017, 19 (06) :537-543
[7]   Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer [J].
Chand, M. ;
Swift, R. I. ;
Tekkis, P. P. ;
Chau, I. ;
Brown, G. .
BRITISH JOURNAL OF CANCER, 2014, 110 (01) :19-25
[8]   Extramural vascular invasion is an adverse prognostic indicator of survival in patients with colorectal cancer [J].
Courtney, E. D. ;
West, N. J. ;
Kaur, C. ;
Ho, J. ;
Kalber, B. ;
Hagger, R. ;
Finlayson, C. ;
Leicester, R. J. .
COLORECTAL DISEASE, 2009, 11 (02) :150-156
[9]   A Review of Current Challenges in Colorectal Cancer Reporting [J].
Dawson, Heather ;
Kirsch, Richard ;
Messenger, David ;
Driman, David .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (07) :869-882
[10]  
Federatie Medisch Specialisten, Colorectaal Carcinoom (CRC)